Medicine and Dentistry
Adalimumab
16%
Alveolar Ridge
50%
Anakinra
16%
Antiviral Immune Response
9%
Blood Donor
54%
Case Fatality Rate
16%
Case-Control Study
50%
Clinician
10%
COVID-19
100%
Diagnosis
20%
Diagnostic Accuracy
10%
Disease Course
100%
Drug Resistant Epilepsy
10%
Epilepsy Surgery
20%
Epilepsy Syndromes
16%
Epileptic Seizure
100%
Epstein Barr Virus
50%
Exercise
50%
Finger Dermatoglyphics
50%
Head and Neck Cancer
50%
Heart Rehabilitation
50%
Hippocampus
18%
Immunoassay
9%
Immunomodulatory Drug
16%
Infection
68%
Jaw
25%
Life Expectancy
50%
Magnetic Resonance Imaging
50%
Middle Age
16%
Mucopolysaccharidosis
50%
Neopterin
9%
Partial Seizure
30%
Patient with Epilepsy
33%
Physical Activity
50%
Physical Medicine and Rehabilitation
16%
Population
37%
Post-COVID-19
50%
Prematurity
16%
Prospective Study
10%
Prosthesis
16%
Prosthetics
33%
Pulvinar
22%
Quality of Life
50%
Reinfection
50%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Short Form 36
16%
Status Epilepticus
100%
Stereoelectroencephalography
50%
Thalamus
22%
Virus Reactivation
50%
Pharmacology, Toxicology and Pharmaceutical Science
Adalimumab
16%
Anakinra
16%
Antivirus Agent
9%
Blister
21%
Case Fatality Rate
16%
Cladribine
8%
Clinical Trial
50%
Deterioration
50%
Disease
11%
Disease Course
100%
Epidermolysis Bullosa Simplex
50%
Epileptic State
50%
Epstein-Barr Virus
50%
Genodermatosis
50%
Heart Disease
50%
Immunoassay
9%
Infection
68%
Life Expectancy
50%
Lysosome Storage Disease
8%
Mucopolysaccharidosis
50%
Neopterin
9%
Normal Human
12%
Premature Mortality
50%
Prematurity
16%
Primary Infection
8%
Public Health Policy
8%
Randomized Controlled Trial
50%
Rare Disease
7%
Reinfection
50%
SARS Coronavirus
100%
Skin Disease
7%
Storage Disease
8%
Syndrome
66%
Virus DNA
9%
Mathematics
Assumed Model
7%
Binary Data
50%
Concludes
7%
Count Data
57%
Covariance Matrix
12%
Crossover
50%
Crossover Design
25%
Dimensional Data
12%
Estimating Equation
25%
Finite Population
50%
Fisher Information Matrix
14%
High Power
50%
Information Gain
14%
Interaction Effect
25%
Marginal Model
50%
Matrix (Mathematics)
50%
Optimal Design
28%
Ordinal Data
50%
Outcome Variable
50%
Pairwise Comparison
50%
Parameter Vector
12%
Parametric Model
25%
Population
50%
Projection Matrix
37%
Quadratic Form
25%
Quantile
12%
Regression Coefficient
12%
Simplex
50%
Statistical Method
25%
Test Statistic
12%
Time Increase
7%
time point η
50%
Treatment Effect
21%
Type Statistic
50%
Upper Triangular
12%
Wald
50%
